143 results on '"Guérin-Charbonnel, Catherine"'
Search Results
2. Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
3. Exclusive autologous fat grafting: Feasibility, satisfaction, and quality of life
4. Individual learning curve of cytoreductive surgery for peritoneal metastasis from colorectal cancer: A process with an impact on survival
5. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
6. How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology.
7. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
8. DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma
9. Supplementary Table 3 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
10. Supplementary Table 4 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
11. Supplementary Figures from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
12. Supplementary Table 2 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
13. Supplementary Table 1 from A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
14. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
15. Impact of consolidation chemotherapy after delayed complete surgery in advanced epithelial ovarian cancer: a propensity score analysis
16. Impact of consolidation chemotherapy after delayed complete surgery in advanced epithelial ovarian cancer: a propensity score analysis.
17. Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study
18. Additional file 3 of The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
19. Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
20. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
21. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses
22. Additional file 3 of DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma
23. Additional file 2 of DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma
24. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
25. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study
26. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
27. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
28. DNA hydroxymethylation reveals transcription regulation networks and prognostic signatures in multiple myeloma
29. Additional file 18: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
30. Additional file 29: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
31. Additional file 5: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
32. Additional file 3: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
33. Additional file 4: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
34. Additional file 9: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
35. Additional file 6: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
36. Additional file 7: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
37. Additional file 8: of Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
38. iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors
39. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients
40. Logic programming reveals alteration of key transcription factors in multiple myeloma
41. Additional file 6: of Gene-expression signature functional annotation of breast cancer tumours in function of age
42. Additional file 5: of Gene-expression signature functional annotation of breast cancer tumours in function of age
43. Additional file 8: of Gene-expression signature functional annotation of breast cancer tumours in function of age
44. Additional file 1: of Gene-expression signature functional annotation of breast cancer tumours in function of age
45. Additional file 9: of Gene-expression signature functional annotation of breast cancer tumours in function of age
46. Additional file 2: of Gene-expression signature functional annotation of breast cancer tumours in function of age
47. Additional file 7: of Gene-expression signature functional annotation of breast cancer tumours in function of age
48. Additional file 4: of Gene-expression signature functional annotation of breast cancer tumours in function of age
49. Additional file 3: of Gene-expression signature functional annotation of breast cancer tumours in function of age
50. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.